To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SDCCAG8TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
238 supporting clones for gene SDCCAG8 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC326670 caudate nucleus .a 1 to 577 1 to 577   tiling clone,   577/577
(100 %)
0 diff
(100 %id)
NM_006642.2   .a 14 to 2616 1 to 2603 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2603/2603
(100 %)
0 diff
(100 %id)
BX477008   .a 36 to 692 1 to 657       657/657
(100 %)
4 diff
(99.4 %id)
DC353260 brain .a 36 to 599 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
BF673425 Prostate .a 36 to 590 1 to 556       556/936
(59 %)
12 diff
(98.8 %id)
DC337262 substantia nigra .a 37 to 613 1 to 577       577/577
(100 %)
1 diff
(99.9 %id)
DC341488 thalamus .a 37 to 618 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DC368069   .a 37 to 587 1 to 555       555/555
(100 %)
5 diff
(99.1 %id)
CA453607 mixed (pool of 40 RNAs) .a 39 to 682 1 to 653       653/749
(87 %)
18 diff
(97.6 %id)
DC421714 uterus .a 50 to 599 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
DB475573 hippocampus .a 51 to 513 1 to 463       463/463
(100 %)
0 diff
(100 %id)
AF161348 cord Blood .a 52 to 1348 29 to 1325       1297/1325
(97 %)
7 diff
(99.5 %id)
AK299212   .a 52 to 2466 1 to 2415 K399R     2415/2415
(100 %)
4 diff
(99.9 %id)
DC301333 bladder .a 52 to 633 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DC354979   .a 52 to 624 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
BP873479 embryonal kidney .a 52 to 497 1 to 446       446/454
(98 %)
3 diff
(99.4 %id)
DC371102   .a 52 to 636 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
DC375063 brain .a 52 to 629 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
BX481975   .a 53 to 617 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
CD695805 normal nasopharynx .a 58 to 602 18 to 561       544/561
(96 %)
6 diff
(99.0 %id)
BI824846 pooled brain, lung, testis .a 58 to 790 1 to 737       737/738
(99 %)
13 diff
(98.3 %id)
BQ424028 eye, retinoblastoma .a 58 to 788 5 to 740       736/841
(87 %)
12 diff
(98.6 %id)
TI_57196945   .a 58 to 790 70 to 806       737/807
(91 %)
18 diff
(97.8 %id)
BI551705 brain, hippocampus .a 60 to 893 1 to 840       840/840
(100 %)
10 diff
(98.9 %id)
BQ441546 testis .a 60 to 826 1 to 778       778/800
(97 %)
31 diff
(96.2 %id)
DA546025   .a 65 to 618 2 to 556   capped   555/555
(100 %)
3 diff
(99.5 %id)
DA716725   .a 67 to 628 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
DA796884 brain .a 67 to 614 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
DA949468 Spleen .a 67 to 618 2 to 556   capped   555/555
(100 %)
4 diff
(99.3 %id)
BI553187 brain, hippocampus .a 68 to 790 1 to 752       585/753
(77 %)
39 diff
(94.9 %id)
DA478277   .a 69 to 644 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
BI258156 cervical carcinoma cell line, cervix .a 77 to 764 1 to 689       689/689
(100 %)
2 diff
(99.8 %id)
BQ890579 eye, normal pigmented retinal epithelium .a 82 to 542 1 to 465       463/1282
(36 %)
11 diff
(99.2 %id)
TI_45235694   .a 85 to 781 62 to 764       703/1060
(66 %)
20 diff
(98.2 %id)
DN998572 bone marrow .a 85 to 692 7 to 616       610/617
(98 %)
8 diff
(98.8 %id)
DA385525 thalamus .a 91 to 687 2 to 598   capped   597/597
(100 %)
2 diff
(99.7 %id)
DA353336 substantia nigra .a 93 to 676 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
BI517411 pooled colon, kidney, stomach .a 93 to 781 1 to 695       695/991
(70 %)
15 diff
(98.5 %id)
BG482794 lung .a 100 to 842 1 to 742       742/759
(97 %)
30 diff
(96.1 %id)
DA786600 brain .a 101 to 677 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
DA985115 synovial membrane tissue from rheumatioidarthritis .a 101 to 660 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BU158877 eye, retinoblastoma .a 117 to 995 23 to 900       878/900
(97 %)
11 diff
(98.8 %id)
CN336496 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 121 to 854 9 to 742       734/742
(98 %)
2 diff
(99.8 %id)
DR005977 Prostate .a 146 to 674 1 to 525       525/525
(100 %)
5 diff
(99.1 %id)
AF250731 placenta .a 170 to 2311 1 to 2142 exact tiling clone,   2142/2142
(100 %)
1 diff
(100.0 %id)
CV030514 mixed .a 170 to 834 1 to 664       664/664
(100 %)
1 diff
(99.9 %id)
AW793862 uterus .a 236 to 428 9 to 201       193/201
(96 %)
6 diff
(97.1 %id)
DA427579 colon .a 327 to 909 2 to 583   capped   582/583
(99 %)
2 diff
(99.7 %id)
DA747612   .a 344 to 905 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
BE280364 choriocarcinoma, placenta .a 490 to 1161 1 to 670       670/670
(100 %)
5 diff
(99.3 %id)
AA372290   .a 714 to 899 1 to 185       185/185
(100 %)
4 diff
(97.9 %id)
DN990715 brain, whole brain .a 775 to 1510 1 to 735       735/735
(100 %)
7 diff
(99.1 %id)
CA454064   .a 875 to 1717 29 to 873       845/925
(91 %)
13 diff
(98.6 %id)
FN131004 breast carcinoma .a 933 to 1031 94 to 1     Submitted on the opposite strand 94/95
(98 %)
5 diff
(94.8 %id)
FN160332 breast carcinoma .a 941 to 1028 1 to 91       91/91
(100 %)
6 diff
(93.5 %id)
AV739466 cord Blood .a 962 to 1348 57 to 430   AAA   376/430
(87 %)
9 diff
(98.0 %id)
AI092201 heart .a 1001 to 1369 391 to 23       369/391
(94 %)
0 diff
(100 %id)
BI000070 head_normal .a 1074 to 1327 251 to 2       250/251
(99 %)
5 diff
(98.1 %id)
BE082195 breast .a 1092 to 1640 549 to 1     Submitted on the opposite strand 544/611
(89 %)
21 diff
(96.6 %id)
BG675881 skin, squamous cell carcinoma .a 1186 to 1953 1 to 777       775/777
(99 %)
15 diff
(98.1 %id)
BE005399 breast_normal .a 1260 to 1480 228 to 10     Submitted on the opposite strand 219/253
(86 %)
7 diff
(97.3 %id)
CD518722 White Matter .a 1349 to 2230 1 to 885       885/885
(100 %)
5 diff
(99.5 %id)
BE172363 head_neck .a 1358 to 1529 130 to 301       172/301
(57 %)
7 diff
(97.7 %id)
BP425392 small intestine .a 1392 to 1907 1 to 516     Submitted on the opposite strand 516/516
(100 %)
1 diff
(99.9 %id)
BG700417 brain, hippocampus .a 1557 to 2263 1 to 703   available from MGC,   703/703
(100 %)
8 diff
(98.9 %id)
BC045832 Brain, hippocampus .a 1562 to 2612 1 to 1051   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1051/1051
(100 %)
0 diff
(100 %id)
DA832333 placenta .a 1605 to 2291 2 to 688   fully sequenced, capped   687/687
(100 %)
6 diff
(99.2 %id)
BG197273   .a 1638 to 2405 1 to 771       771/774
(99 %)
22 diff
(97.2 %id)
BG215583   .a 1638 to 2155 1 to 518       518/810
(63 %)
11 diff
(98.7 %id)
BG206115   .a 1640 to 2428 1 to 790       790/794
(99 %)
17 diff
(97.9 %id)
W29097 eye, retina .a 1641 to 2154 51 to 564       514/859
(59 %)
8 diff
(99.1 %id)
BG209259   .a 1643 to 2425 7 to 787       781/788
(99 %)
23 diff
(97.1 %id)
BG221173   .a 1644 to 2166 9 to 531       523/813
(64 %)
22 diff
(97.3 %id)
BG181727   .a 1652 to 1903 63 to 313       251/313
(80 %)
7 diff
(97.8 %id)
BG193232   .a 1659 to 2419 18 to 771       754/785
(96 %)
24 diff
(97.0 %id)
BG213967   .a 1665 to 2155 90 to 581       492/842
(58 %)
19 diff
(97.8 %id)
FN086163 breast carcinoma .a 1697 to 1755 1 to 59       59/62
(95 %)
1 diff
(98.4 %id)
CN270370 embryonic stem cells, DMSO-treated H9 cellline .a 1949 to 2121 1 to 174       174/174
(100 %)
1 diff
(99.5 %id)
BQ018376 lung, Metastatic Chondrosarcoma .a 1992 to 2618 642 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 626/626
(100 %)
1 diff
(99.9 %id)
CN292722 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2093 to 2439 1 to 347       347/347
(100 %)
3 diff
(99.2 %id)
AI735499 aorta .a 2126 to 2615 490 to 1       490/490
(100 %)
7 diff
(98.6 %id)
DB378466 placenta .a 2251 to 2611 363 to 1   fully sequenced,   363/363
(100 %)
2 diff
(99.5 %id)
AK299249   .b 1 to 2197 12 to 2208 W19R S598G tiling clone,   2197/2197
(100 %)
2 diff
(100.0 %id)
DA750395   .b 1 to 558 12 to 569   capped   558/558
(100 %)
1 diff
(99.9 %id)
AK297105   .c 1 to 2034 2 to 2035 E190D tiling clone,   2035/2035
(100 %)
1 diff
(100.0 %id)
DA474686   .c 1 to 574 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
CN336497 embryonic stem cells, cell lines H1, H7, andH9 .d 1 to 561 12 to 572   tiling clone,   561/572
(98 %)
6 diff
(99.0 %id)
BG722694 testis .d 17 to 748 1 to 735       735/735
(100 %)
10 diff
(98.7 %id)
DB109569 thymus .d 39 to 618 2 to 581   tiling clone, capped   580/580
(100 %)
0 diff
(100 %id)
DA867150 Prostate .d 45 to 582 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA697452   .d 59 to 622 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
AW160598 brain, frontal lobe .d 66 to 521 1 to 456       456/456
(100 %)
0 diff
(100 %id)
BQ347070 nervous_tumor .d 67 to 691 621 to 4       618/624
(99 %)
22 diff
(96.5 %id)
BQ430035 large cell carcinoma, lung .d 271 to 1114 1 to 856   tiling clone,   856/882
(97 %)
27 diff
(97.0 %id)
AF039690 colorectal carcinoma .d 706 to 2256 1 to 1550   tiling clone,   1550/1552
(99 %)
3 diff
(99.9 %id)
CA444908 lung, Metastatic Chondrosarcoma .d 1517 to 1727 227 to 17   AAA   211/218
(96 %)
6 diff
(97.3 %id)
AW392482 stomach .d 1915 to 2162 19 to 268       250/269
(92 %)
12 diff
(95.6 %id)
BF841667 head_neck .d 1917 to 2018 32 to 133       102/133
(76 %)
0 diff
(100 %id)
BG188626   .d 1921 to 2257 1 to 337   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 337/338
(99 %)
12 diff
(96.5 %id)
BG193325   .d 1921 to 2251 1 to 331   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 331/331
(100 %)
1 diff
(99.7 %id)
BG200468   .d 1923 to 2081 1 to 159       159/159
(100 %)
0 diff
(100 %id)
AA883684 pooled .d 1923 to 2255 345 to 12   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 334/334
(100 %)
3 diff
(99.2 %id)
BG221258   .d 1943 to 2251 46 to 357   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 312/357
(87 %)
8 diff
(97.8 %id)
EC477393 Prostate .d 1966 to 2070 1 to 105       105/105
(100 %)
0 diff
(100 %id)
AW057648 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 2039 to 2255 217 to 1       217/217
(100 %)
0 diff
(100 %id)
AI659852 Prostate .d 2044 to 2255 232 to 21   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 212/212
(100 %)
2 diff
(99.1 %id)
AA715235 normal prostate, Prostate .d 2051 to 2255 223 to 20   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 204/204
(100 %)
4 diff
(98.1 %id)
AI963422 adenocarcinoma, Pancreas .d 2112 to 2257 147 to 2   tiling clone,   146/147
(99 %)
0 diff
(100 %id)
T26899   .d 2138 to 2257 120 to 1       120/120
(100 %)
3 diff
(97.5 %id)
BC032454 Brain, Lung, Testis, adult, pooled whole .e 1 to 1650 8 to 1657 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 1657/1657
(100 %)
3 diff
(99.9 %id)
AW150169 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1029 to 1651 624 to 1       624/631
(98 %)
20 diff
(96.9 %id)
BI829962 brain, medulla .e 1046 to 1634 1 to 588       588/589
(99 %)
4 diff
(99.4 %id)
TI_57176647   .e 1046 to 1634 69 to 656       588/657
(89 %)
9 diff
(98.7 %id)
BF988065 placenta_normal .e 1098 to 1490 408 to 15   tiling clone,   394/408
(96 %)
0 diff
(100 %id)
AA633840 lung .e 1432 to 1695 271 to 8       264/271
(97 %)
0 diff
(100 %id)
BJ994074 hepatoblastoma .f 1 to 560 1 to 560   tiling clone,   560/560
(100 %)
0 diff
(100 %id)
BX457273 thymus .f 23 to 855 1 to 833   tiling clone,   833/833
(100 %)
2 diff
(99.8 %id)
BF037689 adenocarcinoma, ovary .f 621 to 1248 1 to 628       628/628
(100 %)
3 diff
(99.6 %id)
AK023586 placenta .f 738 to 2027 1 to 1289   tiling clone, available from FLJ,   1289/1289
(100 %)
1 diff
(100.0 %id)
AU137207 placenta .f 739 to 1411 2 to 674   capped   673/675
(99 %)
10 diff
(98.6 %id)
BF979071 melanotic melanoma, high MDR, skin .f 952 to 1529 1 to 573       573/897
(63 %)
59 diff
(93.5 %id)
CB985300 Pooled-Glandular .f 973 to 1702 1 to 737       737/790
(93 %)
17 diff
(97.9 %id)
CA772630 Pancreas, Purified pancreatic islet .f 1195 to 1604 2 to 411   tiling clone, fully sequenced,   410/411
(99 %)
8 diff
(98.1 %id)
AA017278 eye, retina .f 1251 to 1499 1 to 247       247/249
(99 %)
4 diff
(98.4 %id)
TI_149306076   .f 1320 to 2051 791 to 60       732/986
(74 %)
0 diff
(100 %id)
BM978666 lung, Primary Lung Epithelial Cells .f 1368 to 2045 678 to 1   tiling clone,   678/678
(100 %)
0 diff
(100 %id)
AU157074 placenta .f 1472 to 2027 552 to 1       552/584
(94 %)
16 diff
(97.3 %id)
DW443761 Liver .f 1499 to 1711 17 to 229       213/229
(93 %)
6 diff
(97.4 %id)
DB544392 hippocampus .f 1534 to 2026 1 to 493     Submitted on the opposite strand 493/494
(99 %)
2 diff
(99.6 %id)
CA771784 Pancreas, Purified pancreatic islet .f 1574 to 2033 460 to 1   fully sequenced,   460/460
(100 %)
10 diff
(97.9 %id)
BF247623 hypernephroma, Kidney .f 1576 to 1640 609 to 674       381/676
(56 %)
19 diff
(97.2 %id)
EC553426 Prostate .f 1708 to 1809 1 to 102       102/102
(100 %)
0 diff
(100 %id)
BE049260 adenocarcinoma, Pancreas .f 1975 to 2384 411 to 1       411/411
(100 %)
2 diff
(99.6 %id)
BJ994075 hepatoblastoma .f 2032 to 2461 430 to 1   tiling clone,   430/431
(99 %)
0 diff
(100 %id)
BX112494 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .f 2075 to 2383 323 to 15   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 309/311
(99 %)
0 diff
(100 %id)
AI686992 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .f 2081 to 2383 314 to 11   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 304/304
(100 %)
9 diff
(97.1 %id)
BU949841 Pancreas, Purified pancreatic islet .g 1 to 446 1 to 446   tiling clone,   446/446
(100 %)
0 diff
(100 %id)
CB132804 Liver .g 275 to 823 1 to 549   tiling clone,   549/549
(100 %)
0 diff
(100 %id)
CN336495 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 584 to 906 1 to 323       323/323
(100 %)
3 diff
(99.1 %id)
BU949558 Pancreas, Purified pancreatic islet .g 595 to 1050 456 to 1   tiling clone,   456/456
(100 %)
2 diff
(99.6 %id)
AW513195 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .g 621 to 1046 426 to 1   tiling clone,   426/426
(100 %)
0 diff
(100 %id)
CB993001 placenta, pre-eclamptic placenta .h 1 to 780 29 to 814 Q180S E181G I182N E183R K184E ... tiling clone,   786/819
(95 %)
34 diff
(95.9 %id)
BX474238   .i 1 to 602 1 to 602   tiling clone,   602/602
(100 %)
0 diff
(100 %id)
CN336493 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 6 to 656 1 to 651 exact tiling clone,   654/654
(100 %)
0 diff
(100 %id)
BX444555 adult brain, brain .j 1 to 819 1 to 818 exact tiling clone,   818/818
(100 %)
2 diff
(99.8 %id)
BX452685 adult brain, brain .j 681 to 1559 1 to 871   tiling clone,   871/902
(96 %)
47 diff
(94.8 %id)
BX452686 adult brain, brain .j 681 to 1627 1 to 947   tiling clone,   947/948
(99 %)
12 diff
(98.8 %id)
DB024403 testis .k 1 to 548 2 to 549 exact tiling clone, capped   548/548
(100 %)
0 diff
(100 %id)
BX537630 human fetal brain .l-u 1 to 3758 1 to 3757 D18Y tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 3757/3757
(100 %)
9 diff
(99.8 %id)
BX483536   .l-u 1394 to 2241 1 to 848 D18Y     848/848
(100 %)
7 diff
(99.2 %id)
CV325140 bocio_tumor .l-u 1886 to 2226 340 to 1     Submitted on the opposite strand 340/340
(100 %)
5 diff
(98.6 %id)
BI601147 brain, hypothalamus .l-u 2106 to 2910 1 to 811   tiling clone, available from MGC,   811/811
(100 %)
10 diff
(98.8 %id)
TI_45214271   .l-u 2109 to 2910 83 to 890       808/890
(90 %)
6 diff
(99.4 %id)
BC041942 Brain, hypothalamus .l-u 2111 to 3758 1 to 1648   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1648/1648
(100 %)
1 diff
(100.0 %id)
BI711701 insulinoma, Pancreas .l-u 2237 to 2809 8 to 581     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 574/581
(98 %)
6 diff
(99.0 %id)
BI711782 insulinoma, Pancreas .l-u 2237 to 2769 9 to 542     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 534/542
(98 %)
6 diff
(98.9 %id)
CN288626 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l-u 2332 to 3024 693 to 1   tiling clone, Submitted on the opposite strand 693/693
(100 %)
0 diff
(100 %id)
N47748 multiple sclerosis lesions .l-u 2890 to 3364 1 to 486       486/487
(99 %)
10 diff
(98.0 %id)
N46720 multiple sclerosis lesions .l-u 2901 to 3266 1 to 368       368/388
(94 %)
5 diff
(98.8 %id)
TI_154038817   .l-u 3037 to 3762 778 to 57   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 722/764
(94 %)
11 diff
(98.6 %id)
CA444895 lung, Metastatic Chondrosarcoma .l-u 3117 to 3762 659 to 15   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 645/645
(100 %)
3 diff
(99.6 %id)
AW193663 pooled germ cell tumors .l-u 3176 to 3762 587 to 1       587/587
(100 %)
0 diff
(100 %id)
AI970343 pooled germ cell tumors .l-u 3192 to 3762 571 to 1       571/572
(99 %)
3 diff
(99.5 %id)
BI711290 insulinoma, Pancreas .l-u 3202 to 3762 575 to 15   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 561/561
(100 %)
2 diff
(99.7 %id)
AW195719 pooled .l-u 3289 to 3763 482 to 7       476/482
(98 %)
0 diff
(100 %id)
BI711499 insulinoma, Pancreas .l-u 3299 to 3762 478 to 15   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 464/464
(100 %)
3 diff
(99.4 %id)
AI140814 pooled .l-u 3345 to 3762 433 to 16   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 418/418
(100 %)
0 diff
(100 %id)
AI038590   .l-u 3382 to 3763 384 to 4       381/384
(99 %)
0 diff
(100 %id)
AA886109 metastatic prostate bone lesion .l-u 3391 to 3781 9 to 398       390/398
(97 %)
6 diff
(98.5 %id)
BP389532 pancreatic islet .l-u 3393 to 3777 385 to 1       385/389
(98 %)
0 diff
(100 %id)
AA744290 Prostate, stroma .l-u 3400 to 3830 8 to 437       430/437
(98 %)
6 diff
(98.7 %id)
DA138181 alzheimer cortex .m 1 to 544 2 to 546 exact tiling clone, capped   545/545
(100 %)
1 diff
(99.9 %id)
DB043785 testis .n-u 1 to 581 2 to 584   tiling clone, capped   583/583
(100 %)
2 diff
(99.7 %id)
DA533819 brain .n-u 36 to 609 2 to 588   capped   587/587
(100 %)
16 diff
(97.3 %id)
DA144979 amygdala .n-u 47 to 627 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
T78140 whole brain .n-u 60 to 435 1 to 383       383/435
(88 %)
15 diff
(96.6 %id)
DA309312 hippocampus .n-u 71 to 628 2 to 559   tiling clone, capped   558/558
(100 %)
0 diff
(100 %id)
DB032426 testis .n-u 72 to 623 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
AA449618   .n-u 73 to 537 1 to 463       463/463
(100 %)
2 diff
(99.6 %id)
CN336494 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n-u 251 to 805 1 to 555   tiling clone,   555/555
(100 %)
0 diff
(100 %id)
BC015867 Testis, embryonal carcinoma .n-u 682 to 1241 1 to 560   tiling clone, available from MGC, AAA   560/560
(100 %)
2 diff
(99.7 %id)
BG531853 embryonal carcinoma, testis .n-u 685 to 1245 1 to 562   available from MGC,   562/759
(74 %)
12 diff
(98.5 %id)
BX111512   .n-u 742 to 1241 1 to 500   AAA   500/500
(100 %)
1 diff
(99.8 %id)
AA421360   .n-u 751 to 950 1 to 197   fully sequenced,   197/197
(100 %)
4 diff
(98.0 %id)
AA774426   .n-u 819 to 1243 424 to 1       424/424
(100 %)
2 diff
(99.6 %id)
AA421262   .n-u 920 to 1245 326 to 1   fully sequenced,   326/326
(100 %)
1 diff
(99.7 %id)
AA449359   .n-u 942 to 1241 300 to 1       300/300
(100 %)
2 diff
(99.4 %id)
BF949815 nervous_normal .n-u 974 to 1442 110 to 576       467/610
(76 %)
7 diff
(98.9 %id)
BX119695 germinal center B cell .n-u 1132 to 1926 1 to 796   tiling clone,   796/796
(100 %)
2 diff
(99.8 %id)
AI473707 follicular lymphoma, lymph node .n-u 1650 to 2114 468 to 4       465/468
(99 %)
0 diff
(100 %id)
AI383469 pooled .n-u 1710 to 2117 408 to 1   tiling clone,   408/408
(100 %)
0 diff
(100 %id)
AA456836 germinal center B cell .n-u 1738 to 2117 380 to 1       380/380
(100 %)
0 diff
(100 %id)
BU616964 Cell Line, Chondrosarcoma .o 1 to 692 707 to 16 L12X L21X tiling clone, AAA   692/693
(99 %)
0 diff
(100 %id)
BM555911 amelanotic melanoma, cell line, skin .o 69 to 692 1 to 625   AAA   625/625
(100 %)
5 diff
(99.2 %id)
BM808076 amelanotic melanoma, cell line, skin .o 69 to 692 25 to 648   tiling clone, AAA   624/648
(96 %)
6 diff
(99.1 %id)
BF874713 lung_tumor .o 375 to 745 372 to 2     Submitted on the opposite strand 371/372
(99 %)
0 diff
(100 %id)
DB444354 testis .p 191 to 439 211 to 455 S8Y P48Q N49I L50F S51L ... tiling clone,   455/457
(99 %)
18 diff
(96.1 %id)
CB136505 Liver .q 1 to 286 1 to 286 S3F tiling clone,   286/286
(100 %)
1 diff
(99.7 %id)
AL707925 human skeletal muscle .r 1 to 524 8 to 531   tiling clone,   524/531
(98 %)
6 diff
(98.9 %id)
BX496366 Liver .r 302 to 828 1 to 535 L14X M15D S16V A17C L18T ... tiling clone,   535/535
(100 %)
7 diff
(98.7 %id)
AW900472 nervous_normal .s 1 to 397 7 to 403   tiling clone,   397/403
(98 %)
6 diff
(98.6 %id)
BQ322318 colon_est .s 20 to 444 12 to 435 exact tiling clone,   424/435
(97 %)
7 diff
(98.4 %id)
BG979334 colon_normal .s 26 to 396 1 to 371   tiling clone,   371/371
(100 %)
4 diff
(99.0 %id)
BI000068 head_normal .s 36 to 396 1 to 361       361/361
(100 %)
6 diff
(98.4 %id)
AL518751 brain, neuroblastoma, neuroblastoma cells .t 1 to 996 1 to 990 exact fully sequenced,   990/990
(100 %)
21 diff
(97.9 %id)
CR618020 neuroblastoma .t 2 to 1710 1 to 1709 exact tiling clone,   1709/1709
(100 %)
0 diff
(100 %id)
AL561746 brain, neuroblastoma, neuroblastoma cells .t 966 to 1684 737 to 25   fully sequenced,   713/737
(96 %)
20 diff
(97.3 %id)
BG547901 lung .u 1 to 841 1 to 846 A19S S20K A21C Y22L E23* tiling clone,   846/847
(99 %)
12 diff
(98.6 %id)
BF356125 head_neck .u 94 to 343 1 to 249       249/249
(100 %)
6 diff
(97.6 %id)
BF356124 head_neck .u 149 to 343 1 to 194       194/194
(100 %)
6 diff
(97.0 %id)
CV353809 stomach .u 169 to 428 1 to 258       258/258
(100 %)
23 diff
(91.1 %id)
T48169 fetal spleen, Spleen .va-u 1 to 369 1 to 379   tiling clone, fully sequenced,   379/379
(100 %)
9 diff
(97.7 %id)
BX112599 liver and spleen .va-u 144 to 750 606 to 1 exact tiling clone,   606/606
(100 %)
2 diff
(99.7 %id)
N59539 liver and spleen .va-u 179 to 617 1 to 441 exact   Submitted on the opposite strand 441/441
(100 %)
4 diff
(99.1 %id)
N78280 liver and spleen .va-u 306 to 736 434 to 1 R2*   Submitted on the opposite strand 434/440
(98 %)
6 diff
(98.7 %id)
T51553 fetal spleen, Spleen .va-u 339 to 709 378 to 1   fully sequenced,   378/378
(100 %)
7 diff
(98.2 %id)
TI_158432834   .vb 1 to 641 732 to 91 exact tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 642/893
(71 %)
6 diff
(99.4 %id)
CF528658 placenta .vb 90 to 641 565 to 14 exact AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 552/553
(99 %)
0 diff
(100 %id)
N50307 multiple sclerosis lesions .vc-u 1 to 228 1 to 234   tiling clone, fully sequenced,   234/234
(100 %)
1 diff
(99.6 %id)
N47096 multiple sclerosis lesions .vc-u 198 to 560 363 to 1   tiling clone, fully sequenced,   363/363
(100 %)
1 diff
(99.8 %id)
DA386818 thalamus .vd 1 to 529 2 to 530 exact tiling clone, capped   529/529
(100 %)
0 diff
(100 %id)
BG621206 placenta .ve 1 to 526 1 to 525 exact tiling clone,   525/736
(71 %)
3 diff
(99.6 %id)
BG192240   .ve 64 to 528 1 to 466       466/468
(99 %)
5 diff
(99.0 %id)
BG206711   .ve 64 to 528 1 to 466       466/469
(99 %)
10 diff
(97.9 %id)
BG184934   .ve 67 to 521 491 to 37     Submitted on the opposite strand 455/491
(92 %)
4 diff
(99.2 %id)
BG195981   .ve 67 to 247 194 to 14     Submitted on the opposite strand 181/194
(93 %)
1 diff
(99.5 %id)
BG216054   .ve 67 to 508 442 to 1     Submitted on the opposite strand 442/442
(100 %)
11 diff
(97.6 %id)
BG221260   .ve 67 to 521 495 to 41     Submitted on the opposite strand 455/495
(91 %)
2 diff
(99.6 %id)
AW028371 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .ve 93 to 527 434 to 1       434/479
(90 %)
3 diff
(99.4 %id)
AI445418 adenocarcinoma, Pancreas .ve 143 to 527 410 to 26       385/410
(93 %)
0 diff
(100 %id)
AI266387 placenta .ve 168 to 528 365 to 5       361/365
(98 %)
0 diff
(100 %id)
AI288955 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .ve 170 to 529 360 to 1   tiling clone,   360/360
(100 %)
0 diff
(100 %id)
AW021346 cochlea, ear .vf 1 to 404 1 to 405 exact tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 405/405
(100 %)
6 diff
(98.6 %id)
BI492219 cochlea, ear .vf 219 to 408 212 to 23   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 190/190
(100 %)
0 diff
(100 %id)
AI948670 Kidney .vg 1 to 324 324 to 1 exact tiling clone,   324/324
(100 %)
0 diff
(100 %id)
AI478382 Kidney .vg 2 to 324 323 to 1 exact     323/323
(100 %)
0 diff
(100 %id)
BF512324   .vg 98 to 327 244 to 15   tiling clone, AAA   230/240
(95 %)
0 diff
(100 %id)
AW946683 lung_tumor .vh-u 1 to 219 1 to 227 T3R Q4C Q5T R6E E7K ... tiling clone,   227/239
(94 %)
25 diff
(89.6 %id)
AW946595 lung_tumor .vh-u 20 to 215 21 to 215   tiling clone,   195/215
(90 %)
6 diff
(97.3 %id)
AW946696 lung_tumor .vh-u 40 to 220 1 to 180   tiling clone,   180/192
(93 %)
9 diff
(95.4 %id)
AK023517 placenta Gene SDCCAG8, variant not shown       available from FLJ,      
DB296134 bladder Gene SDCCAG8, variant not shown         This clone was ignored    
DA045322 bladder Gene SDCCAG8, variant not shown       capped This clone was ignored    
DB300343 cerebellum Gene SDCCAG8, variant not shown              
DA118740 cerebellum Gene SDCCAG8, variant not shown       capped      
DB300678 cerebellum Gene SDCCAG8, variant not shown              
DA123927 cerebellum Gene SDCCAG8, variant not shown       capped      
AV718346 hypothalamus Gene SDCCAG8, variant not shown         Suspected internal deletion, this clone was ignored    
AV649496 corresponding non cancerous liver tissue Gene SDCCAG8, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AW005183 anaplastic oligodendroglioma, brain Gene SDCCAG8, variant not shown         This clone was ignored    
BE541039 cervix Gene SDCCAG8, variant not shown         Suspected internal deletion, this clone was ignored    
AU156393 placenta Gene SDCCAG8, variant not shown              
AU135962 placenta Gene SDCCAG8, variant not shown       capped      
DB151599 thymus Gene SDCCAG8, variant not shown       capped This clone was ignored    
DB346178 thymus Gene SDCCAG8, variant not shown         This clone was ignored    
BM697746 eye, fetal eyes Gene SDCCAG8, variant not shown       fully sequenced, This clone was ignored    
BU736029 eye, fetal eyes Gene SDCCAG8, variant not shown       fully sequenced, This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n-u, .o, .p, .q, .r, .s, .t, .u, .va-u, .vb, .vc-u, .vd, .ve, .vf, .vg, .vh-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C